These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247 [TBL] [Abstract][Full Text] [Related]
8. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315 [TBL] [Abstract][Full Text] [Related]
9. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [TBL] [Abstract][Full Text] [Related]
10. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413 [TBL] [Abstract][Full Text] [Related]
11. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938 [TBL] [Abstract][Full Text] [Related]
13. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578 [TBL] [Abstract][Full Text] [Related]
14. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
16. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231 [TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759 [TBL] [Abstract][Full Text] [Related]